NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more
Market Cap & Net Worth: NIOX Group PLC (NIOX)
NIOX Group PLC (LSE:NIOX) has a market capitalization of $3.00 Million (GBX24.66 Billion) as of March 18, 2026. Listed on the LSE stock exchange, this UK-based company holds position #43082 globally and #698 in its home market, demonstrating a -4.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NIOX Group PLC's stock price GBX59.00 by its total outstanding shares 417939265 (417.94 Million).
NIOX Group PLC Market Cap History: 2015 to 2026
NIOX Group PLC's market capitalization history from 2015 to 2026. Data shows change from $15.43 Million to $3.00 Million (-13.26% CAGR).
Index Memberships
NIOX Group PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$41.09 Million | 0.08% | #40 of 722 |
Weight: NIOX Group PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NIOX Group PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NIOX Group PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
NIOX Group PLC's market cap is 0.08 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.87x
NIOX Group PLC's market cap is 0.87 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $917.97K | $34.60 Million | -$48.30 Million | 0.03x | N/A |
| 2020 | $1.36 Million | $23.90 Million | -$33.50 Million | 0.06x | N/A |
| 2020 | $1.36 Million | $23.90 Million | -$33.50 Million | 0.06x | N/A |
| 2021 | $1.96 Million | $27.90 Million | $3.60 Million | 0.07x | 0.54x |
| 2021 | $1.96 Million | $27.90 Million | $3.60 Million | 0.07x | 0.54x |
| 2022 | $1.76 Million | $31.30 Million | $16.10 Million | 0.06x | 0.11x |
| 2022 | $1.76 Million | $31.30 Million | $16.10 Million | 0.06x | 0.11x |
| 2023 | $3.36 Million | $36.80 Million | $10.70 Million | 0.09x | 0.31x |
| 2023 | $3.36 Million | $36.80 Million | $10.70 Million | 0.09x | 0.31x |
| 2024 | $3.20 Million | $41.80 Million | $3.70 Million | 0.08x | 0.87x |
Competitor Companies of NIOX by Market Capitalization
Companies near NIOX Group PLC in the global market cap rankings as of March 18, 2026.
Key companies related to NIOX Group PLC by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
NIOX Group PLC Historical Marketcap From 2015 to 2026
Between 2015 and today, NIOX Group PLC's market cap moved from $15.43 Million to $ 3.00 Million, with a yearly change of -13.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX3.00 Million | -11.14% |
| 2025 | GBX3.38 Million | +5.40% |
| 2024 | GBX3.20 Million | -4.66% |
| 2023 | GBX3.36 Million | +90.55% |
| 2022 | GBX1.76 Million | -10.10% |
| 2021 | GBX1.96 Million | +43.97% |
| 2020 | GBX1.36 Million | +48.42% |
| 2019 | GBX917.97K | -60.42% |
| 2018 | GBX2.32 Million | -53.85% |
| 2017 | GBX5.02 Million | +10.64% |
| 2016 | GBX4.54 Million | -70.56% |
| 2015 | GBX15.43 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NIOX Group PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.00 Million USD |
| MoneyControl | $3.00 Million USD |
| MarketWatch | $3.00 Million USD |
| marketcap.company | $3.00 Million USD |
| Reuters | $3.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.